Mid Atlantic Retina

Mid Atlantic Retina Wills Eye Retina Doctors providing the latest treatments for diseases of the retina, macula, and vitreous in Pennsylvania, New Jersey, and Delaware.

Mid Atlantic Retina is an internationally recognized, pre-eminent retina practice in Pennsylvania, New Jersey and Delaware, delivering state-of-the-art, comprehensive patient care for over 40 years. Our practice is dedicated to the diagnosis and treatment of retina, vitreous and macula disorders, with the goal of improving the quality of life of our patients. World-Renowned, Wills Eye Retina Surgeons

All of our doctors are:
>Certified by the American Board of Ophthalmology;
>Faculty members at Wills Eye Institute and Jefferson Health System;
>Involved in patient care, innovative clinical trial research and medical writing.
>Attention-to-Detail for Treatment & Surgery
>Our 22 retina specialists utilize the most advanced therapies and surgical approaches, combined with an unfailing attention to consistency and detail, to provide the best treatment available. On the Leading Edge of Technology - All of our offices have the latest diagnostic and therapeutic services. We Keep Our Patients Informed - by providing information on common diseases in print and on our website. Easily Accessible Offices - Our offices are easy to find, with multiple locations throughout the tri-state area. Thank you for visiting the Mid Atlantic Retina fan page! We welcome your participation but do ask that you be respectful of the entire community by complying with the terms and policies of Facebook. Please refrain from posting any comments that could be considered profane, derogatory, verbally abusive, or those that contain solicitation of any sort. Any comments we view as inappropriate will be removed.

For the second year in a row, Mid Atlantic Retina has been recognized as the  #1 ophthalmology practice with the most do...
03/03/2026

For the second year in a row, Mid Atlantic Retina has been recognized as the #1 ophthalmology practice with the most doctors on the 2026 Castle Connolly Top Doctors list. Congratulations to all our physicians for their dedication to our patients, research, and education for retinal disease. View the full list here - https://castleconnolly.com

At the Hawaiian Eye 2026 meeting, Allen Ho, MD spoke about the recent progress and future development of gene therapy an...
03/03/2026

At the Hawaiian Eye 2026 meeting, Allen Ho, MD spoke about the recent progress and future development of gene therapy and what it could mean for patients with wet age-related macular degeneration.

WAIKOLOA, Hawaii — The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026. Allen C. Ho, MD, of Wills Eye Hospital, said gene therapy started in the subretinal space with gen...

02/25/2026

The Pennsylvania Academy of Ophthalmology has honored Drs. Allen Ho and Nellie Shields for their work starting and growing Wills Eye on Diabetes Day.

The annual event serves as a statewide initiative for diabetic eye screenings. Stay tuned for more information on this year's event, happening on April 25.

Age-Related Macular Degeneration is the leading cause of blindness among older Americans. Call us to schedule your AMD e...
02/23/2026

Age-Related Macular Degeneration is the leading cause of blindness among older Americans. Call us to schedule your AMD exam - 1.800.331.6634

Monday, February 23: Due to inclement weather, all Mid Atlantic Retina offices are closed. Patients with appointments wi...
02/23/2026

Monday, February 23: Due to inclement weather, all Mid Atlantic Retina offices are closed. Patients with appointments will be contacted to reschedule.

02/19/2026

What’s the difference between Wet and Dry Age-Related Macular Degeneration? Sonia Mehta, MD and Ajay Kuriyan, MD answer your AMD questions.

In this perspective for Healio, Dr. Jordan Deaner shares insights on the FDA's clearance of investigational new drug app...
02/18/2026

In this perspective for Healio, Dr. Jordan Deaner shares insights on the FDA's clearance of investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious anterior uveitis.

The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious anterior uveitis, according to a press release from Novaliq.The randomized, double-masked EYETAC clinical trial will evaluate NOV05 (tacrolimus ophthalmic solution in EyeSol) in pati...

Do you know your risk? Seniors 65 and older are the age group most likely to develop Age-Related Macular Degeneration. C...
02/17/2026

Do you know your risk? Seniors 65 and older are the age group most likely to develop Age-Related Macular Degeneration. Call us to schedule your AMD exam - 1.800.331.6634.

Happy Valentine's Day! Love your eyes today and treat yourself to some sweets. According to the American Academy of Opht...
02/14/2026

Happy Valentine's Day! Love your eyes today and treat yourself to some sweets. According to the American Academy of Ophthalmology, dark chocolate has been proven to improve blood flow, which can help sharpen your vision.
http://bit.ly/ShowEyesLove

What Does Macular Degeneration vision look like? Learn the facts about AMD from the top retinal specialists.
02/12/2026

What Does Macular Degeneration vision look like? Learn the facts about AMD from the top retinal specialists.

How Long Does It Take to Lose Vision With Macular Degeneration? Details on vision loss in macular degeneration & how to slow its progression.

How does age-related macular degeneration affect your vision? Watch this simulator by the National Eye Institute to see ...
02/10/2026

How does age-related macular degeneration affect your vision? Watch this simulator by the National Eye Institute to see how you and your loved ones see with AMD.

Updated version of this video: https://youtu.be/Cb58xLev3I4Watch to learn more about age-related macular degeneration (AMD), which causes blurriness or spots...

02/06/2026

What is Age-Related Macular Degeneration? It’s time to Ask Your Retina Doc! Sonia Mehta, MD and Ajay Kuriyan, MD answer common AMD questions.

Address

4060 Butler Pike Ste 200
Plymouth Meeting, PA
19462

Alerts

Be the first to know and let us send you an email when Mid Atlantic Retina posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Mid Atlantic Retina:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Mid Atlantic Retina is an internationally recognized, pre-eminent retina practice in Pennsylvania, New Jersey and Delaware, delivering state-of-the-art, comprehensive patient care for over 40 years. Our practice is dedicated to the diagnosis and treatment of retina, vitreous and macula disorders, with the goal of improving the quality of life of our patients. World-Renowned, Wills Eye Retina Surgeons All of our doctors are: Certified by the American Board of Ophthalmology; Faculty members at Wills Eye Institute and Jefferson Health System; Involved in patient care, innovative clinical trial research and medical writing. Attention-to-Detail for Treatment & Surgery Our 20 retina specialists utilize the most advanced therapies and surgical approaches, combined with an unfailing attention to consistency and detail, to provide the best treatment available. On the Leading Edge of Technology - All of our offices have the latest diagnostic and therapeutic services. We Keep Our Patients Informed - By providing information on common diseases in print and on our website. Easily Accessible Offices - Our offices are easy to find, with multiple locations throughout the tri-state area. Thank you for visiting the Mid Atlantic Retina fan page! We welcome your participation but do ask that you be respectful of the entire community by complying with the terms and policies of Facebook. Please refrain from posting any comments that could be considered profane, derogatory, verbally abusive, or those that contain solicitation of any sort. Any comments we view as inappropriate will be removed.